These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 29525651)
1. On the Road from Gene to Therapy in Inherited Cardiomyopathies. Limongelli G; Bossone E; Elliott PM; Day SM Heart Fail Clin; 2018 Apr; 14(2):xi-xv. PubMed ID: 29525651 [No Abstract] [Full Text] [Related]
2. Prospects for adenovirus-mediated gene therapy of inherited diseases of the myocardium. Bowles NE; Wang Q; Towbin JA Cardiovasc Res; 1997 Sep; 35(3):422-30. PubMed ID: 9415286 [No Abstract] [Full Text] [Related]
8. Genetic advances in sarcomeric cardiomyopathies: state of the art. Ho CY; Charron P; Richard P; Girolami F; Van Spaendonck-Zwarts KY; Pinto Y Cardiovasc Res; 2015 Apr; 105(4):397-408. PubMed ID: 25634555 [TBL] [Abstract][Full Text] [Related]
9. Genetic engineering and therapy for inherited and acquired cardiomyopathies. Day S; Davis J; Westfall M; Metzger J Ann N Y Acad Sci; 2006 Oct; 1080():437-50. PubMed ID: 17132800 [TBL] [Abstract][Full Text] [Related]
10. The role of mutations in the SCN5A gene in cardiomyopathies. Zaklyazminskaya E; Dzemeshkevich S Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1799-805. PubMed ID: 26916278 [TBL] [Abstract][Full Text] [Related]
13. Somatic gene transfer and cardiac arrhythmias: problems and prospects. Tomaselli GF; Donahue JK J Cardiovasc Electrophysiol; 2003 May; 14(5):547-50. PubMed ID: 12776876 [No Abstract] [Full Text] [Related]
14. A straightforward guide to the sarcomeric basis of cardiomyopathies. Lopes LR; Elliott PM Heart; 2014 Dec; 100(24):1916-23. PubMed ID: 25271316 [TBL] [Abstract][Full Text] [Related]
15. Timing and Implementation of Viral Gene Therapy for Cardiomyopathy. McNally EM JACC Heart Fail; 2024 Apr; 12(4):771-775. PubMed ID: 38569827 [No Abstract] [Full Text] [Related]
16. Sudden cardiac death in inherited cardiomyopathy. Collis R; Elliott PM Int J Cardiol; 2017 Jun; 237():56-59. PubMed ID: 28532587 [TBL] [Abstract][Full Text] [Related]
17. Selective HDL-Raising Human Apo A-I Gene Therapy Counteracts Cardiac Hypertrophy, Reduces Myocardial Fibrosis, and Improves Cardiac Function in Mice with Chronic Pressure Overload. Amin R; Muthuramu I; Aboumsallem JP; Mishra M; Jacobs F; De Geest B Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930153 [TBL] [Abstract][Full Text] [Related]
18. Information technology solutions to support translational research on inherited cardiomyopathies. Bellazzi R; Larizza C; Gabetta M; Milani G; Bucalo M; Mulas F; Nuzzo A; Favalli V; Arbustini E Stud Health Technol Inform; 2011; 169():907-11. PubMed ID: 21893878 [TBL] [Abstract][Full Text] [Related]